Scientist I/II, Analytical Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Genezen · 2 months ago

Scientist I/II, Analytical Development

Genezen is a company focused on gene therapy and the development of GMP viral vectors for clinical trials. The Scientist I/II in Analytical Development will lead the establishment of methods in the lab, focusing on the development and validation of analytical assays while ensuring compliance with cGMP standards.

BiotechnologyGeneticsManufacturing
badNo H1Bnote

Responsibilities

Expert in HPLC based methodology development and establishment including with the use of CAD and MALS detectors for use in the characterization of AAV vectors
Expected to be able to operate HPLC associated equipment including equipment troubleshooting as required
Familiarity with OpenLab software for the analysis of HPLC based readouts
Maintain familiarity with other current analytical and bioassay methods, including Flowcytometry, ELISA, qPCR and ddPCR based assays in Lenti, Retro and AAV platforms
Maintain familiarity with current equipment used in Analytics lab
Help management evaluate new technology and bring new platforms in-house
Qualify/Validate analytical methods to support cGMP testing
Help facilitate tech transfer of analytical and bioassays from clients to AD lab and from AD lab to QC lab
Supervise and train AD Associates and AD Technicians and work closely with other departments, assisting in project planning
Support the establishment of electronic record keeping systems for site; e.g. LIMS or ELN
Analyze regulatory authorities’ programs, guidance documents, and activities in areas relevant to testing of biological products
Work as a team with process development, manufacturing, quality assurance and quality control departments as needed
Advise site and quality management of potential and actual actions that could adversely affect the business, represent quality exposures, or represent opportunities to be pursued
Execute research timelines to meet program and corporate objectives
Deal with abstract and concrete variables in situations where only limited standardization exists
Maintain high quality deliverables and open communication, creating a collaborative working environment
Contribute to collaborative, creative and rigorous culture of scientific discovery
Provide weekly reports to department head in 1:1 environment

Qualification

HPLC methodology developmentBiophysical characterization of AAVBioanalytical method validationOpenLab softwareMass Spectrometry (LCMS)People training skillsTroubleshooting skillsProject managementVerbal communicationWritten communication

Required

BS in scientific/technical discipline
2-4 years of CRO/CDMO experience in design, development and execution of bioanalytical methods (i.e. method development, qualification, validation and transfer). Methods include, but are not limited to: HPLC using UV-Vis, CAD, and MALS detectors, qPCR, ddPCR, ELISA, cell based assays (potency, infectivity, etc) and flow cytometry-based assays
Expertise in the biophysical characterization of AAV particles and associated impurities
Experience with documentation and reporting of results using electronic lab notebooks
People training and leadership skills
Ability to maintain multiple projects and timelines
Excellent verbal and written communication skills
Extremely high levels of initiative, adaptability, tenacity and troubleshooting skills

Preferred

Mass Spectrometry emphasis on LCMS

Benefits

Paid vacation days, amount based on tenure
Paid sick time
10 observed holidays + 2 floating holiday + 1 volunteer day
401(k) plan with company match up to 6% of salary, vested immediately
Share Appreciation Rights
Choice of several healthcare plans
FSA and HSA programs
Dental & vision care
Employer-paid basic term life/personal accident insurance
Voluntary disability, universal life/personal accident insurance
Accidental Death & Dismemberment (AD&D) Insurance

Company

Genezen

twittertwittertwitter
company-logo
Genezen offers contract process development, GMP viral vector production, transduced cell manufacturing, and testing services.

Funding

Current Stage
Growth Stage
Total Funding
$18.5M
Key Investors
Ampersand Capital Partners
2023-11-02Series Unknown· $18.5M

Leadership Team

leader-logo
Steven J. Favaloro
Chairman & CEO
linkedin
leader-logo
Michael Wourms
Chief Operations Officer
linkedin
Company data provided by crunchbase